Hokkaido University, or Hokudai, is a Japanese national university in Sapporo, Hokkaido. It was the fifth Imperial University in Japan, which were established to be the nation's finest institutions of higher education or research.

During the past decade, Hokkaido University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hokkaido University" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hokkaido University" are "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Cancer of Rectum" (1 trials), "Chronic Hepatitis C" (1 trials), "Microscopic Polyangiitis" (1 trials) and "Wegener Granulomatosis" (1 trials). Many other conditions were trialed in "Hokkaido University" in a lesser frequency.

Most popular intervention types in "Hokkaido University" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Glucocorticoids" (1 trials), "Ipilimumab" (1 trials), "Nivolumab" (1 trials), "Rituximab" (1 trials) and "elbasvir, grazoprevir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hokkaido University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hokkaido University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hokkaido University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hokkaido University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".